Catalyst Pharmaceuticals Inc
NASDAQ:CPRX

Watchlist Manager
Catalyst Pharmaceuticals Inc Logo
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
Watchlist
Price: 25.55 USD -2.89% Market Closed
Market Cap: 3.1B USD

Intrinsic Value

The intrinsic value of one CPRX stock under the Base Case scenario is 20.7 USD. Compared to the current market price of 25.55 USD, Catalyst Pharmaceuticals Inc is Overvalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CPRX Intrinsic Value
20.7 USD
Overvaluation 19%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Catalyst Pharmaceuticals Inc

Valuation History Unavailable

Historical valuation for CPRX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare CPRX to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CPRX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Catalyst Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Catalyst Pharmaceuticals Inc

Current Assets 685.7m
Cash & Short-Term Investments 580.7m
Receivables 72.2m
Other Current Assets 32.8m
Non-Current Assets 223.2m
Long-Term Investments 24.2m
PP&E 3.4m
Intangibles 147.3m
Other Non-Current Assets 48.2m
Efficiency

Free Cash Flow Analysis
Catalyst Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Catalyst Pharmaceuticals Inc

Revenue
534.6m USD
Cost of Revenue
-74.2m USD
Gross Profit
460.4m USD
Operating Expenses
-229m USD
Operating Income
231.4m USD
Other Expenses
-34m USD
Net Income
197.4m USD
Fundamental Scores

CPRX Profitability Score
Profitability Due Diligence

Catalyst Pharmaceuticals Inc's profitability score is 82/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Free Cash Flow
Exceptional 3-Years Revenue Growth
Positive Gross Profit
82/100
Profitability
Score

Catalyst Pharmaceuticals Inc's profitability score is 82/100. The higher the profitability score, the more profitable the company is.

CPRX Solvency Score
Solvency Due Diligence

Catalyst Pharmaceuticals Inc's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
93/100
Solvency
Score

Catalyst Pharmaceuticals Inc's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CPRX Price Targets Summary
Catalyst Pharmaceuticals Inc

Wall Street analysts forecast CPRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CPRX is 34.68 USD with a low forecast of 31.31 USD and a high forecast of 42 USD.

Lowest
Price Target
31.31 USD
23% Upside
Average
Price Target
34.68 USD
36% Upside
Highest
Price Target
42 USD
64% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Catalyst Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CPRX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CPRX Insider Trading
Buy and sell transactions by insiders

CPRX News

Other Videos
What is the Intrinsic Value of one CPRX stock?

The intrinsic value of one CPRX stock under the Base Case scenario is 20.7 USD.

Is CPRX stock undervalued or overvalued?

Compared to the current market price of 25.55 USD, Catalyst Pharmaceuticals Inc is Overvalued by 19%.

Back to Top